Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Carlyle buys majority stake in Knack, EqualizeRCM to build AI-led healthcare billing platform
The private equity firm is betting on consolidation in a fragmented US billing services market, with plans to scale via acquisitions and global delivery
Carlyle acquires Knack RCM and Equalize RCM to create an AI-native, global multi-specialty healthcare RCM platform
Global investment firm Carlyle has acquired a majority stake in US healthcare revenue cycle management providers Knack RCM and EqualizeRCM. This move aims to create a global, AI-native, multi-specialty RCM platform. The combined entity will leverage AI and global delivery to enhance operational scale and client outcomes, addressing critical financial risks for healthcare providers.
Here's why these two healthcare stocks are surging up to 10% on Monday
Healthcare stocks are in focus today, with shares of Dr Lal PathLabs and Aster DM Healthcare rallying after their March quarter earnings and upbeat brokerage commentary.
Buy, Sell Or Hold: Kalyan Jewellers, Bajaj Auto, Eternal, Siemens Energy And Max Healthcare — Ask Profit
Experts shared buy, sell and hold recommendations on NDTV Profit's 'Ask Profit' show.
India's healthcare expansion faces a critical talent crunch, says Alisha Moopen
Aster DM Healthcare is gearing up for a significant upgrade, targeting a capacity of 15,000 beds by the fiscal year 2029. With plans driven by both natural growth and an ambitious merger, the company is optimistic about a surge in revenue and enhanced profit margins.
Cantor Fitzgerald raises Acadia Healthcare stock price target on valuation By Investing.com - Investing.com India
Cantor Fitzgerald raises Acadia Healthcare stock price target on valuation By Investing.comInvesting.com India
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.
Aster DM Healthcare Q4 revenue jumps 18% YoY to Rs 1,182 crore
Aster DM Healthcare reported an 18% year-on-year revenue increase in Q4 to Rs 1,182 crore, with operating EBITDA up 31%. The company is on track to complete its merger with Quality Care India Ltd in Q1 FY27, creating a combined entity with over 10,600 beds.
Aster DM Healthcare consolidated net profit rises 77.39% in the March 2026 quarter
Sales rise 18.20% to Rs 1182.38 crore
Aster DM Healthcare profit jumps 77% on strong patient growth and lab performance
Shares of Aster DM Healthcare Ltd ended at ₹705.00, up by ₹5.55, or 0.79%, on the BSE.
56% YTD return! Healthcare stock retraces after showing resilience against stock market crash. Should you buy? - Mint
56% YTD return! Healthcare stock retraces after showing resilience against stock market crash. Should you buy?Mint
Sanofi Consumer Healthcare Q1 net profit surges 36% as export sales jump 144%
Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,708.10, up by ₹60.65, or 1.31%, on the BSE.